The long-term outcomes of the first prospective, multi-institutional, single-arm study of patients with prostate cancer treated with salvage radical prostatectomy after disease recurrence following radiotherapy have recently been published. Durable oncological control was reported, possibly because most patients had low-risk or intermediate-risk prostate cancer at initial diagnosis and the biochemical progression-free survival interval was long.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mottet, N. et al. EAU – ESTRO – ESUR – SIOG guidelines on prostate cancer. uroweb https://uroweb.org/wp-content/uploads/09-Prostate-Cancer_2017_web.pdf (2017).
Van den Broeck, T. et al. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review. Eur. Urol. https://doi.org/10.1016/j.eururo.2018.10.011 (2018).
Nguyen, P. L. et al. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure. Cancer 110, 1417–1428 (2007).
Agarwal, P. K. et al. Treatment failure after primary and salvage therapy for prostate cancer. Cancer 112, 307–314 (2008).
Kumar, R. J., Barqawi, A. & Crawford, E. D. Adverse events associated with hormonal therapy for prostate cancer. Rev. Urol. 7 (Suppl. 5), 37–43 (2005).
Mohler, J. L. et al. Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-018-0106-1 (2018).
Chade, D. C. et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur. Urol. 61, 961–971 (2012).
Kane, C. J. et al. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology 61, 607–611 (2003).
Calais, J. et al. Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage radiotherapy planning. J. Nucl. Med. 59, 230–237 (2018).
Kaffenberger, S. D. & Smith, J. A. Salvage robotic radical prostatectomy. Indian J. Urol. 30, 429–433 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Devos, G., Joniau, S. Salvage prostatectomy for recurrent disease. Nat Rev Urol 16, 150–151 (2019). https://doi.org/10.1038/s41585-018-0143-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-018-0143-5
